O

OrbiMed Portfolio holdings

AUM $4.17B
1-Year Est. Return 30.9%
This Quarter Est. Return
1 Year Est. Return
+30.9%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.45B
AUM Growth
+$454M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
130
New
Increased
Reduced
Closed

Top Buys

1
+$54.1M
2
+$47.9M
3
+$40.9M
4
QTTB icon
Q32 Bio
QTTB
+$38.4M
5
ESPR icon
Esperion Therapeutics
ESPR
+$36.7M

Top Sells

1
+$147M
2
+$93.5M
3
+$84.9M
4
SWTX
SpringWorks Therapeutics
SWTX
+$74.4M
5
THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
+$71.7M

Sector Composition

1 Healthcare 99.34%
2 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
101
$2.03M 0.04%
23,777
102
$1.75M 0.03%
560,319
103
$1.74M 0.03%
192,700
104
$1.53M 0.03%
448,891
105
$1.41M 0.03%
+113,500
106
$1.24M 0.02%
297,380
107
$1.1M 0.02%
153,443
-170,188
108
$498K 0.01%
2,648,386
109
$445K 0.01%
+9,975
110
$278K 0.01%
18,023
111
$178K ﹤0.01%
+80,420
112
– –
-79,400
113
– –
-58,800
114
– –
-100,000
115
– –
-109,900
116
– –
-31,148
117
– –
-4,707,458
118
– –
0
119
– –
-1,347,900
120
– –
-35,177
121
– –
-117,000
122
– –
-386,100
123
– –
-4,803,200
124
– –
-9,308,726
125
– –
-17,713,600
2 3 4
5
6